Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
SCHOTT Pharma Plans to Invest US$371 million in California, USA
SCHOTT Pharma plans to invest US$371 million to open new prefillable syringe manufacturing facility in California, USA
Simtra BioPharma Solutions Invests US$250 million to Construct New Manufactuting Site in Indiana, USA
Simtra BioPharma Solutions invests US$250 million to construct new sterile fillfinish manufacturing site in Indiana, USA
Experic to Open New Facility to Support Clinical Trials & Logistic Services in Ireland, Europe
Experic plans to open new facility to support global clinical trial storage and logistics services in Ireland, Europe
Adare Pharma Solutions Expands its Packaging & Warehousing Capabilities In Italy, Europe
Adare Pharma Solutions plans to expand its packaging and warehousing capabilities at its Pessano facility in Italy, Europe
Pharmascience Invests US$120 million to Expand Sterile Injectable Manufacturing Facility in Canada
Pharmascience invests US$120 million to expand its sterile injectable manufacturing facility in Candiac site
National Resilience Invests US$225 million to Increase Cartridge Fill/Finish Capabilities in Cincinnati, USA
National Resilience plans to invest US$225 million to increase PFS and Cartridge fillfinish capabilities in Cincinnati, USA
Daiichi Sankyo Invests US$1.12 billion (€1 billion) to Expand Innovation Centre in Munich, Germany
Daiichi Sankyo with an investment of US$112 billion plans to expand production and development site in Pfaffenhofen an daer Ilm in Germany
Bristol Myers Squibb Invests US$400 million to Expand Sterile Drug Product Facility in Dublin, Ireland
Bristol Myers Squibb invests US$400 million to expand its campus in Dublin, Ireland, by incorporating a new sterile drug product facility
SCHOTT Pharma Plans to Open New Production Facility in Jagodina, Serbia
SCHOTT Pharma is investing a multimillioneuro investment to open a stateoftheart production facility for pharmaceutical drug containment solutions and delivery systems in Jagodina, Serbia
AstraZeneca Invests US$300 million to Open New Manufacturing Facility in Maryland, USA
AstraZeneca invests US$300 million to open a stateoftheart manufcaturing facility in Maryland, USA The Rockville facility aims to enhance its manufacturing
